DEU0003386MA - - Google Patents
Info
- Publication number
- DEU0003386MA DEU0003386MA DEU0003386MA DE U0003386M A DEU0003386M A DE U0003386MA DE U0003386M A DEU0003386M A DE U0003386MA
- Authority
- DE
- Germany
- Prior art keywords
- ergot
- hydrastis
- alkaloids
- active ingredients
- remedies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000735429 Hydrastis Species 0.000 claims description 5
- 229960003133 ergot alkaloid Drugs 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 241000735432 Hydrastis canadensis Species 0.000 claims description 4
- 235000005679 goldenseal Nutrition 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- 230000000087 stabilizing effect Effects 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 2
- 239000003381 stabilizer Substances 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229930013930 alkaloid Natural products 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000002908 adrenolytic effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- OFKDAAIKGIBASY-VFGNJEKYSA-N ergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C3=CC=CC4=NC=C([C]34)C2)=C1)C)C1=CC=CC=C1 OFKDAAIKGIBASY-VFGNJEKYSA-N 0.000 description 1
- 229960004943 ergotamine Drugs 0.000 description 1
- XCGSFFUVFURLIX-UHFFFAOYSA-N ergotaminine Natural products C1=C(C=2C=CC=C3NC=C(C=23)C2)C2N(C)CC1C(=O)NC(C(N12)=O)(C)OC1(O)C1CCCN1C(=O)C2CC1=CC=CC=C1 XCGSFFUVFURLIX-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0279382B1 (de) | Warzenmittel | |
| DE69021396T2 (de) | Tabakersatz. | |
| DE2117429B2 (de) | Verfahren zur Herstellung eines Injektions- bzw. Infusionspräparates mit einem Gehalt an einem Wirkstoffgemisch aus den Blättern von Ginkgo biloba | |
| DE2404416A1 (de) | Neurotropisch wirksames mittel und verfahren zu seiner herstellung | |
| DE2206570B2 (de) | Verwendung von ( + ) - Catechin | |
| DE2758942A1 (de) | Kautabletten mit einem gehalt an erythromycin | |
| DE3885798T2 (de) | Proteinhaltiges Polysaccharid zur Behandlung retroviraler Infektionen. | |
| DE951757C (de) | Verfahren zum Stabilisieren von Mutterkornalkaloiden | |
| DE2348805A1 (de) | Nahrungsmittel-komposition und verfahren zur herstellung derselben | |
| DE3635522A1 (de) | Pharmazeutische zusammensetzung | |
| EP0259617A2 (de) | Verfahren und Präparat zur Inaktivierung von Viren | |
| DE2916573A1 (de) | Arzneimittel und verfahren zu seiner herstellung | |
| DE149731C (enExample) | ||
| DE962781C (de) | Verfahren zur Erzeugung einer Vitamin-D-reichen Hefezubereitung | |
| DE2752339C3 (de) | Arzneimittel mit Depotwirkung zur Behandlung des Mammakarzinoms | |
| DE317509C (enExample) | ||
| DE338166C (de) | Verfahren zur Herstellung unschaedlicher Impfstoffe aus gifthaltigen pathogenen Mikroorganismen | |
| DE2036113A1 (de) | Tetramisolpraparate | |
| DE2208576A1 (de) | Medikament zur Behandlung von Al koholvergiftungen | |
| DE1767616C (de) | Heilmittel gegen Nosema und Milben bei Bienen, sowie Verfahren zu seiner Her Stellung | |
| DE2150921C2 (de) | Chemotherapeutisch wirksame, zwei Wirkstoffe enthaltende Präparate | |
| DE2048926C2 (de) | Antihypertensives Kombinationspräparat | |
| DE651597C (de) | Verfahren zur Darstellung haltbarer Hormonpraeparate | |
| DE1218114B (de) | Verfahren zur Herstellung von Toxoiden aus Bakterientoxinen | |
| DE132608C (enExample) |